Carl Figdor - Selected publications#


1. Lesterhuis W.J., Punt C.J., Hato S.V., Eleveld-Trancikova D., Jansen B.J., Nierkens S., Schreibelt G., de Boer A., Van Herpen C.M., Kaanders J.H., van Krieken J.H., Adema G.J., Figdor C.G., de Vries I.J. Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. J Clin. invest 2011; 121:3100-3108 (IF 14.152; Cited 37).
2. Buschow SI, Figdor CG. Dendritic cell subsets digested: RNA sensing makes the difference! Immunity. 2010 Feb 26;32(2):149-51. (IF 24.221; Cited 9).
3. vanZanten, T.S., Cambi, A., Koopman, M., Joosten, B., Figdor, C.G*., Garcia-Parajo*, M.F. Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. Proc Natl Acad Sci U S A, 2009. 106(44): 18557-62. (*equal contribution) (IF 9.771; Cited 36).
4. Tacken, P.J., de Vries, I.J., Torensma, R., Figdor, C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol, 2007. 7(10): 790-802. (IF 35,169; Cited 197).
5. deVries, I.J., Lesterhuis, W.J., Barentsz, J.O., Verdijk, P., van Krieken, J.H., Boerman, O.C., Oyen, W.J., Bonenkamp, J.J., Boezeman, J.B., Adema, G.J., Bulte, J.W., Scheenen, T.W., Punt, C.J., Heerschap, A., Figdor, C.G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol, 2005. 23(11): 1407-13. (IF 31,085; Cited 325).
6. Tacken, P.J., de Vries, I.J., Gijzen, K., Joosten, B., Wu, D., Rother, R.P., Faas, S.J., Punt, C.J., Torensma, R., Adema, G.J., Figdor, C.G. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood, 2005. 106(4): 1278-85. (IF 10.558; Cited 119).
7. Figdor, C.G., de Vries, I.J., Lesterhuis, W.J., Melief, C.J. Dendritic cell immunotherapy: mapping the way. Nat Med, 2004. 10(5): 475-80. (IF 25,430; Cited 516).
8. De Vries, I.J., Krooshoop, D.J., Scharenborg, N.M., Lesterhuis, W.J., Diepstra, J.H., Van Muijen, G.N., Strijk, S.P., Ruers, T.J., Boerman, O.C., Oyen, W.J., Adema, G.J., Punt, C.J., Figdor, C.G. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res, 2003. 63(1): 12-7. (IF 8,234; Cited 223).
9. Geijtenbeek, T.B., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C., Adema, G.J., van Kooyk, Y., Figdor, C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell, 2000. 100(5): 575-85. (IF 32.401; Cited 938).
10. Geijtenbeek, T.B., Kwon, D.S., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C., Middel, J., Cornelissen, I.L., Nottet, H.S., KewalRamani, V.N., Littman, D.R., Figdor, C.G., van Kooyk, Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell, 2000. 100(5): 587-97. (IF 32.401; Cited 938).
Imprint Privacy policy « This page (revision-2) was last updated on Wednesday, 12. December 2012, 23:58 by Kaiser Dana
  • operated by